Tech Deals

Daily Archives: February 13, 2013

Lux Capital is investing in areas of science that many venture capitalists have backed away from.

Photograph by Zomi

Lux Capital is investing in areas of science that many venture capitalists have backed away from.

Lux Capital Raises $245 Million to Fund Unpopular Science Startups

Over the past half-decade, venture capitalists have been retreating from biotech and energy, burned by bad bets and turned off by excessive costs. Meanwhile, one firm with former executives from Pfizer and the Central Intelligence Agency is doubling down. Lux...

Read more »